Related Experiment Video
Updated: Jan 17, 2026

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
Published on: August 29, 2025
The 50th Anniversary Conference - Caxambu 2024
Renata Rosito Tonelli1, Daniel José Galafasse Lahr2, Elvira Maria Saraiva3
1Universidade Federal de São Paulo, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Departamento de Ciências Farmacêuticas, Diadema, SP, Brasil.
Insights
This conference highlighted advancements in Chagas disease (CD) research, focusing on parasite adaptability, host interactions, and new treatments. Efforts are underway to improve diagnosis, prevention, and public engagement for this neglected tropical disease.
Area of Science:
- * Tropical Medicine
- * Parasitology
- * Infectious Diseases
Background:
- * Chagas disease (CD), caused by Trypanosoma (Schizotrypanum) cruzi, poses a significant global health threat, particularly in Latin America.
- * The Brazilian Society of Protozoology (SBPz) convened experts to discuss five decades of progress in CD research.
- * The conference aimed to synthesize current knowledge and foster future research directions.
Purpose of the Study:
- * To review recent breakthroughs in understanding the genetic and metabolic adaptability of Trypanosoma cruzi.
- * To explore novel insights into host-parasite interactions driving Chagas disease pathogenesis.
- * To assess progress in drug development, diagnostics, and prevention strategies for Chagas disease.
Main Methods:
- * Synthesis of research findings presented at the SBPz conference.
- * Expert discussions on parasite biology, host-pathogen interactions, and therapeutic interventions.
- * Review of ongoing clinical trials and biomarker/vaccine development initiatives.
Main Results:
- * Advances in understanding parasite adaptability, including genomic compartmentalization and metabolic flexibility.
- * New insights into inflammatory and vascular processes contributing to CD progression, especially cardiac involvement.
- * Identification of treatment limitations and the urgent need for novel therapeutic candidates, alongside progress in benznidazole (BZN) and nifurtimox (NFX) regimens.
- * Progress in biomarker discovery and vaccine development for improved diagnosis, prognosis, and prevention.
- * Emphasis on science communication and public health engagement to enhance disease awareness and access to care.
Conclusions:
- * Multidisciplinary research integrating molecular biology with public policy is crucial for combating Chagas disease.
- * Continued innovation in drug development, diagnostics, and preventative measures is essential.
- * Enhanced science communication and public health initiatives are vital for effective disease control and management.
Abstract:
Chagas disease (CD), caused by Trypanosoma (Schizotrypanum) cruzi, remains a major global health concern, particularly in Latin America, where millions are at risk. To mark five decades of Chagas research, the Brazilian Society of Protozoology (SBPz) hosted a four-day conference held in Caxambu, Minas Gerais, Brazil, from November 3 to 7, 2024. The meeting brought together world-renowned experts from diverse disciplines whose work has significantly advanced the boundaries of CD studies. Key discussions focused on the parasite's genetic and metabolic adaptability, with special emphasis on genomic compartmentalisation, RNA processing, and metabolic flexibility essential for survival and pathogenesis. New insights into host-parasite interactions highlighted inflammatory and vascular remodelling processes that drive parasite dissemination and disease progression, especially in cardiac tissue. In the area of drug development, researchers noted treatment limitations, the urgency for novel therapeutic candidates, and ongoing clinical trials assessing alternative regimens of benznidazole (BZN) and nifurtimox (NFX). Progress in biomarker discovery and vaccine development was also discussed as pivotal to improving disease diagnosis, prognosis, and prevention. Beyond laboratory research, the meeting highlighted the importance of science communication and public health engagement. Outreach initiatives and educational exhibitions were showcased as tools to raise awareness and enhance access to disease diagnosis and treatment. Altogether the integration of multidisciplinary approaches from molecular biology to public policy underscores the enduring commitment to combating CD through research, collaboration, and innovation.
Related Concept Videos
Review and Preview
Review and Preview
Percentiles are a type of fractile that partition data into...
Feedback Loops
Feedback Inhibition
Response Surface Methodology
The process of RSM involves several key steps:
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

